Cognitive Impairments in Psychotic Disorders

计划入组 200 人 · 首次发布于 2022 年 10 月 28 日

Magnetic Seizure Therapy for Psychotic Disorders

计划入组 50 人 · 首次发布于 2024 年 9 月 3 日

Efficiency of Art-therapy in Psychotic Disorders

计划入组 9 人 · 首次发布于 2015 年 3 月 9 日

Perazine

C₂₀H₂₅N₃S

Aripiprazole(Abilify, Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), Abilify Maintena, Aripiprazole Accord, Aripiprazole Sandoz, Aripiprazole Zentiva)

C₂₃H₂₇Cl₂N₃O₂ · Rx

GPR139 antagonists (CNS disorders/motor disorders)

Institute For Neurodegenerative Disorders

United States

Ascendis Pharma Growth Disorders A/S

Denmark

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Psychedelics Show Promise in Clinical Settings but Require Enhanced Safety Monitoring

Denovo Biopharma Partners with Orygen for Phase 2 Trial of Novel Glutamate-Targeting Drug in Early Psychosis

FDA Approves Iloperidone (Fanapt®) for Acute Treatment of Bipolar I Disorder